Kellner Capital’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-29,200
Closed -$1.36M 30
2023
Q2
$1.36M Buy
+29,200
New +$1.01M 1.56% 18

Kellner Capital's DICE Position: Q3 2023 in Review

Kellner Capital sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 29,200 shares — an estimated $1.36M sold.

Kellner Capital first reported a position in DICE in Q2 2023 and held it in 1 quarter. The position peaked at $1.36M in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

  • Kellner Capital reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Kellner Capital sold 29,200 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $1.36M.
  • Kellner Capital first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • Kellner Capital's DICE Therapeutics, Inc. Common Stock position peaked at $1.36M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Kellner Capital's 13F filing for Q3 2023, filed 13 Nov 2023.